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Introduction
Failure to generate a reliable and robust respiratory rhythm compromises body function and can be fatal. In humans, perturbations in the rhythm are most commonly manifest as sleep disordered breathing (SDB), as occurs during sleep apnea, congenital central hypoventilation syndrome (CCHS), several neurodegenerative diseases, and perhaps, sudden infant death syndrome. An essential component of the respiratory rhythm generating circuitry in mammals is the preBötzinger Complex (preBötC; (1-3)), of which approximately 300 neurons per side in the rat express high levels of the neurokinin 1 receptor (NK1R; (4)). Bilateral ablation of preBötC NK1R-expressing neurons by the toxin saporin conjugated to substance P (SP-SAP) leads to an irreversible deterioration of breathing pattern, initially during sleep, progressing to an ataxic breathing pattern during wakefulness (4, 5) . We propose that loss of preBötC NK1R neurons can underlie SDB in humans (5) .
SDB affects a large proportion of the adult population (6) and has a detrimental impact on everyday life, from excessive daytime sleepiness (7) and impaired cognitive function (8) , to increased prevalence of stroke (9) and mortality (10) . SDB is characterized by hypopneas, i.e., periods of reduced ventilation, and apneas, i.e., periods of respiratory cessation resulting either from a transient occlusion of the upper airway (obstructive sleep apnea: OSA) or loss in central respiratory drive (central sleep apnea: CSA). OSA is the most common type of apnea in young adults, with CSA becoming increasingly prevalent with age (11, 12) . CSA is common during both NREM and REM stages of sleep in both humans and rats when serotonin and norepinephrine neurons are inactive throughout the brain (13) . This sleep-related withdrawal of excitation combined with disruption of respiratory rhythm generating mechanisms in the brainstem, e.g., by neurogeneration, may be an underlying cause of CSA and explain why this disorder is exacerbated in the elderly and in some patients with certain neurodegenerative diseases. Developing a model of CSA would greatly enhance our understanding of the neural mechanisms underlying SDB and aid in the development of preventative pharmacological tools.
The aim of this study was to develop a stable model of SDB and to determine if partial ablation of the preBötC leads to a disruption in breathing pattern that is exacerbated during sleep. We hypothesized that unilateral preBötC NK1R ablation would result in SDB, but unlike bilateral ablation of the preBötC would not lead to an ataxic breathing pattern during wakefulness. Some of the results of these studies have been previously reported in the form of an abstract (14) .
METHODS (see online supplement for details)

Surgical Procedures
All experimental procedures were approved by the Chancellor's Animal Research Committee (UCLA). Male Sprague-Dawley rats (n=12, 250-350g) were implanted with electrodes to record: diaphragm electromyography (EMG); neck EMG; and electroencephalography (EEG). Two weeks later a second surgery was performed to stereotaxically micro-inject either the toxin saporin conjugated to substance P (SP-SAP, 100-150 nl; 6.7 ng; n=9; Advanced Targeting Systems, San Diego, CA, USA) or SP mixed with but not conjugated to SAP (unconjugated, control, n=3), unilaterally into the left preBötC.
Data acquisition and analysis
Rats were housed in a room with a 12-hour light/dark cycle. Data were acquired using Chart 5 software (Powerlab 16SP, AD Instruments, Colorado Springs, CO, USA), amplified (Grass Model P511K, Grass Instrument Co., West Warwick, RI, USA), filtered (EEG: 0.3-100 Hz, EMG: 10-100 Hz, ECG: 10-100 Hz) and sampled at 1000 Hz. Data acquired within a 2-hour period (between 12h00 and 18h00, light cycle) every day post-injection were analyzed. Responses to hypercapnia and hypoxia were tested during wakefulness pre-and post-injection.
Sleep and wakefulness were determined from visual inspection, analysis of neck EMG activity and the fast Fourier transform of the EEG signal in 10 s epochs at delta (0.3-5 Hz), theta (6-9 Hz) and sigma (10-15 Hz) frequency bands. Only data when the rat was asleep and in quiet wakefulness were analyzed.
Changes in breathing frequency and amplitude were measured on a breath-by-breath basis using whole body plethysmography (Buxco Electronics Inc., New York, NY, USA).
A constant airflow (2 l/min) was delivered through the plethysmographic chamber and respiratory parameters quantified by recording pressure fluctuations, relative to a reference chamber, that are proportional to tidal volume (differential pressure transducer, DRAL501, Honeywell Data Instruments, Golden Valley, MN, USA). Inspiratory amplitude (I amp ) was calculated from the plethysmographic pressure signal output (in millivolts); control (pre-injection) data were normalized to 1 and all data acquired on subsequent days were rescaled relative to control. Spontaneous respiratory disturbances were defined as hypopnea when inspiratory amplitude <0.5 of normalized control values and apnea when termination of breathing >2s (~3 missed breaths). Respiratory disturbances are expressed as number of episodes normalized to 1 hour each of wakefulness (WAKE), NREM, and REM. All data are expressed as mean±S.E.M.
Statistical analyses were performed using a two-way repeated measures analysis of variance (ANOVA), with post hoc Bonferoni analysis for individual comparisons (StatView software, Abacus Concepts). Differences were regarded as significant if p<0.05.
Histology
Rats were transcardially perfused between days 21-51 post-injection, the brainstem was sectioned at 40 µm and stained for one or two of the following primary antibodies: rabbit anti-NK1R (1:20,000, Chemicon, Temecula, CA, USA); goat anti-choline acetyl transferase (ChAT 1:400, Chemicon); mouse anti-tyrosine hydroxylase (1:500, Chemicon). Under light microscopy (Zeiss, Axioplan2, Carl Zeiss, Thornwood, NY, USA) the extent of the lesion was determined by counting NKIR immunopositive soma in a series of transverse sections representing ~20% of the preBötC, within a circle of 600 µm diameter representing the extent of the preBötC (4), and in a rectangle (1600 x 1070 µm) outside this circle to determine the extent of NKIR neuronal damage outside the preBötC. The mapped sections were at least 160 µm apart to eliminate double counting, beginning with the section in which the rostral border of the lateral reticular nucleus was identified, to the section that included the caudal end of the facial nucleus.
RESULTS
As we previously reported, electrode implantation surgery did not change breathing frequency when compared to pre-electrode implantation ((5); 115±15 vs 127±14 breaths/min; p>0.05). Following injection surgery, all rats appeared lethargic and had shallow breathing. In those rats that were injected unilaterally with SP mixed with but not conjugated to SAP (unconjugated, control), breathing frequency returned to pre-injection levels by day 3 post-injection as we have previously reported ((5); 121±6 breaths/min; n=3), and respiratory disturbances, i.e., hypopneas and apneas, at day 10 post-injection did not significantly differ from pre-injection (WAKE 4±0.12, NREM 4±0.12, REM 6±2.0 episodes/hour; p>0.05).
In rats injected unilaterally with SP-SAP, breathing pattern that had been shallow following injection surgery returned to pre-injection levels by day 3 post-injection (134±23 breaths/min; n=9; p>0.05) and remained normal for up to six days after injection. Breathing disturbances became evident during sleep between days 6-9 post injection (Fig 1) . These disturbances were most frequent during REM sleep (36.8±7.4 episodes/hour, 5.5±0.7 s , Fig 2; n=6; p<0.004) but were also evident during NREM sleep (NREM 15.3±5.3 episodes/hour, 4.3±0.3 s , Fig 2; n=6; p>0.05; (5)). The disturbances were characterized by hypopneas that occasionally led to short periods with neither airflow nor diaphragmatic EMG inspiratory activity, i.e., CSA. In some cases the rats woke up at the end of the apnea and resumed breathing, in other cases the rats resumed breathing while remaining asleep. Compared to pre-injection, breathing was not disturbed during wakefulness, breathing remained stable with no change in frequency (preinjection: 115±15 vs day 21 post-injection: 127±27 breaths/min, p>0.05).
Rats that were monitored up to 51 days post-injection (n=2) continued to have SDB, while breathing during wakefulness remained unchanged (Fig 1) . Unlike bilaterally injected rats (4, 5) , breathing pattern during sleep in unilateral injected rats did not substantially deteriorate after about day 10. At no time did the rats develop a respiratory disturbance during every period of sleep. When a respiratory disturbance occurred, it was characterized by hypopnea that in most cases developed into a CSA upon transition to REM (15.4±9.4 episodes/hour, 5.9±0.7s , Fig 2; n=2; p<0.05). CSA did not occur exclusively in REM but occurred more frequently in REM compared to NREM (Fig 2) and sleep pattern post-unilateral injection was more fragmented compared to pre-injection. When the rats aroused from a CSA, it was usually a gentle transition to wakefulness, with slight head movement and very little body movement, rather than an abrupt arousal that is seen after bilateral injection when breathing pattern is highly disrupted due to frequent respiratory disturbances (4, 5) .
Chemosensitivity
Bilateral ablation of preBötC NK1R neurons blunts the ventilatory response to hypercapnia and hypoxia during wakefulness (4) . To see if this were the case following unilateral ablation, awake rats were exposed to hypercapnic and hypoxic inhaled gas mixtures. In unilateral SP-SAP injected rats, there was no significant difference in the frequency response during wakefulness to hypercapnia when tested on days 3, 9, 15 and 21 post-unilateral SP-SAP injection compared to pre-injection (pre-injection: 164±18; post-injection day 3: 167±13; day 9: 173±21; day 15: 185±9; day 21: 201±16; p>0.05; Fig 3) . When compared to the hypercapnic response of rats injected with SP mixed with but not conjugated to SAP (unconjugated, control), frequency at all time points was not significantly different (p>0.05; Fig 3) .
In response to hypoxia, there was no significant difference in the frequency response during wakefulness to hypoxia when tested on days 3, 9, 15 and 21 post unilateral SP-SAP injection compared to pre-injection (pre-injection: 185±12; post-injection day 3: 185±30; day 9: 179±12; day 15: 182±6; day 21: 218±10; p>0.05; Fig 3) . When compared to the hypoxic frequency response of rats injected with SP mixed with but not conjugated to SAP (unconjugated, control) there was no significant difference (p>0.05; Fig 3) .
Histology
The accumulating bilateral loss of preBötC neurons leads to a progressive disturbance in breathing that is initially seen during sleep, eventually leading to an ataxic breathing pattern when >80% of preBötC NKIR neurons are ablated (4, 5) . Here, unilateral were damaged. There was no significant neuronal loss in other regions examined, e.g.
solitary tract, motor nucleus of vagus, retrotrapezoid nucleus, similar to the results reported in our previous studies using the same injection protocol (4, 5) . Also, there was no reduction in the number of tyrosine hydroxylase expressing neurons that are intermingled with but do not express NK1R, thus confirming the selectivity of the toxin.
DISCUSSION
Unilateral destruction of preBötC NK1R neurons leads to SDB that was stable for up to 7
weeks, while breathing during wakefulness was only very slightly affected. Unlike bilateral ablation of the preBötC, an ataxic breathing pattern did not develop (4, 5) .
Transitions between sleep and wake states induce changes in ventilation, with SDB common, even in healthy individuals (15) , and exaggerated in many diseases and in the elderly. SDB is a significant health problem in adults (6), greatly impacting quality of life (7)(8). CSA, characterized by an absence of respiratory effort, is less common in young adults but becomes increasingly prevalent with age (11, 12) , even in elderly individuals who are relatively "healthy" (16) . The etiology of CSA is presently unknown; however, we show here and have shown previously (5) that disruption of preBötC function may be an underlying or contributing cause. In humans, CSA regularly occurs as part of a periodic breathing pattern and has a co-morbidity with congestive heart failure (17). The waxing and waning Cheyne-Stokes pattern of respiration that is commonly seen in patients with congestive heart failure was not seen in the unilaterally injected rats. In all rats, only apneas of central origin were recorded, evident due to the lack of diaphragmatic EMG activity. Obstructive events were not observed, likely because the upper airway anatomy and sleeping position of rats is not conducive for OSA. We concede that some CSA may be representative of mixed apnea commonly seen in humans (18) . A mixed apnea can begin as central but becomes obstructive upon the restoration of diaphragmatic contraction. The close relationship between CSA and OSA highlights the need to understand the underlying mechanisms and participation of CSA in the manifestation of SDB, even if in the healthy, non-elderly adult, CSA accounts for only a small number of SDB events.
In humans, respiratory disturbances can result from medullary damage (19) (5, 30) , then this would explain the high incidence of SDB in PD, MSA and ALS patients.
As with bilateral lesions, unilateral SP-SAP-induced respiratory disturbances were first evident during REM sleep, then also in NREM sleep; but unlike bilateral lesions, unilateral preBötC ablation did not progress to an ataxic breathing pattern during wakefulness (4, 5) . In rats, and humans (particularly the elderly), irregular breathing and spontaneous CSA occur during both REM (12, 32, 33) The preBötC is a bilateral cluster of functionally heterogeneous neurons, including glutamatergic (41) neurons that are anatomically defined by high levels of NK1R expression (42) and somatostatin mRNA (43) , located just ventral to the nucleus ambiguous in the rostroventrolateral medulla (42, 43) . In this study there was slight damage to the nucleus ambiguous; however, the pathological changes in breathing observed here (see also (4, 5) ) cannot be attributed to a small amount of upper airway motoneuronal damage within the nucleus ambiguous. Neither can the observed changes be attributed to the destruction of inspiratory premotor neurons that are also located within and adjacent to this area (41) 
Conclusions
Unilateral preBötC ablation results in SDB, while breathing during resting wakefulness is only very slightly affected, and in most cases, is relatively normal. Over time, breathing during sleep does not improve, while breathing during wakefulness remains stable. We hypothesize that disruption of preBötC function in the brainstem is an underlying cause of CSA (5) Unilateral ablation of preBötC NK1R neurons does not significantly alter responses to hypoxia and hypercapnia during wakefulness.
In response to hypercapnia (5% CO 2, 21% O 2 , 84% N 2 ), there was a significant increase in respiratory frequency compared to that in room air both pre-and post-injection Neuronal profiles counted within a circle of 600 µm diameter representing the extent of the preBötC (See Fig 5) were reduced in the side injected with SP-SAP compared to the non-injected side. There was some damage to NK1R expressing neurons located within a rectangular area (1600 x 1070 µm) outside this circle (See Fig 5) . On the non-injected side there was no damage to NK1R neurons, as determined by comparison to noninjected control rats.. 
Experimental Protocol
Rats were housed in a room with a 12 hour light/dark cycle (light period from 09h30 -21h30). During periods of data collection, rats were monitored within a plethysmograph, allowing the rats to move freely, with food and water available ad libitum. Post-injection, data were acquired for 9 hours/day (between 10h00 -19h00) during the light cycle. Rats were constantly monitored for any weight loss or infection; rats showing such signs were euthanized by a fatal injection of pentobarbitone (80 mg/kg i.p. Sleep and wakefulness were determined from visual inspection, and analysis of neck EMG activity and the fast Fourier transform of the EEG signal in 10 s epochs at delta (0.3-5 Hz), theta (6-9 Hz) and sigma (10-15 Hz) frequency bands, based on the criteria defined by Benington (3). In the awake state the EEG is a low amplitude, high frequency signal, low delta power, low theta*sigma power and high EMG activity; in NREM sleep the EEG signal is a high amplitude, low frequency signal, high delta power, moderate theta*sigma power and low EMG activity; in REM sleep the EEG is a low amplitude, high frequency signal, low delta power, high theta*sigma power and low to absent EMG activity. Movement distorted the signals and prevented reliable measurements; only data when the rat was asleep and in quiet wakefulness were analyzed.
Changes in breathing frequency and amplitude were measured on a breath-by-breath basis using whole body plethysmography (Buxco Electronics Inc., New York, NY, USA). Within each section, neurons that were positively stained for NK1R were counted within a circle of 600 µm diameter representing the extent of the preBötC (2), and in a rectangle (1600 x 1070 µm) outside this circle (Fig 4 & 5 in manuscript) to determine the extent of NKIR neuronal damage out with the preBötC. The mapped sections were at least 160 µm apart to eliminate double counting.
